General meeting
2026
22 Sep 2026
Extraordinary General Meeting 2026
Hansa Biopharma AB (publ), Reg. No. 556734-5359 (“Hansa Biopharma”), with registered office in Lund, will hold its Extraordinary General Meeting on September 22, 2026 at 15:00 CEST at Hansa Biopharma’s office on Scheelevägen 22, SE-223 63 Lund. Registration starts at 14:30 CEST.
Notice to Extraordinary General Meeting 2026The Nomination Committee of Hansa Biopharma AB (publ)’s reasoned statement to the Extraordinary General Meeting 2026Proxy FormNotification of attendance and form for advance votingProposed articles of associationBoard RSU 2026:2 – Grant notice and agreementAuditor's statement pursuant to Chapter 19, Section 35 with reference to Chapter 13, Section 6 of the Swedish Companies Act (2005:551) regarding the Board of Directors' Report concerning events of material significance for the period 2026-03-25 – 2026-08-21The board of directors’ report in accordance with Ch. 19 Sec. 35 of the Swedish Companies Act, with reference to Ch. 13 Sec. 6 of the Swedish Companies Act
1 Jun 2026
Annual General Meeting 2026
Hansa Biopharma AB (publ), Reg. No. 556734-5359 (“Hansa Biopharma”), with registered office in Lund, will hold its Annual General Meeting on Monday June 1, 2026 at 14:30 CEST, Elite Hotel Ideon, Scheelevägen 27, SE-223 63 Lund. Registration starts at 14:00 CEST.
Notice to Annual General Meeting 2026Notification of attendance and form for advance voting - Hansa Biopharma AGM 2026Proxy Form - Hansa Biopharma AGM 2026The Nomination Committee of Hansa Biopharma AB’s reasoned statement to the Annual General Meeting 2026Auditor's opinion according to Chapter 8, Section 54 of the Swedish Companies Act (2005:551) on whether the Annual General Meeting's guidelines on remuneration to senior executives have been followed (SWE)Corporate Governance Report 2025Remuneration Report 2025Board RSU 2026 in Hansa Biopharma AB (publ)The Board of Directors’ complete proposal for a long-term incentive program 2026 (item 18)TERMS AND CONDITIONS FOR WARRANTS SERIES 2026/2034 IN HANSA BIOPHARMA AB (PUBL) (APPENDIX A.1)TERMS AND CONDITIONS FOR WARRANTS SERIES 2026/2030 IN HANSA BIOPHARMA AB (PUBL) (APPENDIX B.1)Bulletin from the Annual General Meeting 2026Minutes from Annual General Meeting 2026